Mechanisms of erythroid differentiation
Mechanisms of erythroid differentiation
批准号:
6989400
负责人:
PAUL A NEY
金额:
$25.5万
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-12-15 至 2010-05-31
关键词:
Friend leukemiaFriend virusbinding proteinsbiological signal transductioncell differentiationcell proliferationcell transformationdisease /disorder modelerythropoiesiserythropoietingene expressiongenetically modified animalsgrowth factor receptorslaboratory mousemass spectrometrymicroarray technologyphenotypeposttranslational modificationsprotein protein interactionprotein structureproteomicsreceptor expressionsite directed mutagenesistranscription factorviral leukemogenesisvirus geneticsvirus protein
中文摘要
描述(由申请人提供):影响成熟红细胞产生的疾病对公众健康有重大影响。我们的长期目标之一是了解调节终末红细胞分化的信号转导途径。为此,我们采用了一种称为Friend病的病毒/小鼠红细胞分化模型。在之前的资助期内,我们定位克隆了对Friend病易感性所需的宿主因子Fv2。我们确定Fv2编码受体酪氨酸激酶Stk (Sf-Stk)的截断版本。除了对Friend病的机制有明确的含义外,这一结果开始对红细胞分化的调节产生深刻的见解。感染Friend病毒诱导贫血株(FVA细胞)的红细胞发生促红细胞生成素(Epo)依赖的终末分化。失去Epo的FVA细胞发生凋亡。在这里,我们提出的证据表明,促红细胞生成素受体(Epor)信号不仅在FVA细胞存活中起作用,而且也是诱导终末分化所必需的。此外,转录因子信号换能器和转录激活器-5a和-5b (Stat5ab)是必需的。我们的目标是阐明Stat5下游诱导分化的途径。在FVA细胞中,我们假设Stat5激活靶基因的表达,这些基因反馈Sf-Stk和/或Epor信号以诱导终末分化。为了验证这一假设,我们提出了一系列的实验。我们的第一个目标是定义stat5依赖通路。我们建议用微阵列识别直接的Stat5靶点;确定Sf-Stk和Epor下游信号通路中stat5依赖的变化;鉴定细胞蛋白中stat5依赖性的变化和翻译后修饰;确定stat5依赖性蛋白相互作用的变化;并绘制出翻译后修饰位点。我们的第二个目标是研究特定的Stat5靶点在FVA细胞分化中的作用。我们建议研究已知Stat5靶点Cis和Socs3在Cis-/-小鼠FVA细胞和Socs3-/-胎儿肝细胞移植受体FVA细胞中的作用。我们还建议研究潜在的Stat5靶点胰岛素受体底物-2 (Irs2)在来自Irs2-/-小鼠的FVA细胞中的作用。Irs2激活一些与远端Epor相同的信号通路。因此,我们将确定Irs2在正常红细胞中是否与远端Epor在功能上是冗余的。
英文摘要
DESCRIPTION (provided by applicant): Diseases that affect the production of mature erythrocytes have a major impact on public health. One of our long term goals is to understand the signal transduction pathways that regulate terminal erythroid differentiation. Towards that end, we have adopted a viral/murine model of erythroid differentiation known as Friend disease. In the previous funding period, we positionally cloned a host factor Fv2 that is required for susceptibility to Friend disease. We determined that Fv2 encodes a truncated version of the receptor tyrosine kinase Stk (Sf-Stk). Besides clear implications for the mechanism of Friend disease, this result is beginning to yield insights into the regulation of erythroid differentiation. Erythroblasts infected with the anemia-inducing strain of Friend virus (FVA cells) undergo Erythropoietin (Epo)-dependent terminal differentiation. FVA cells deprived of Epo undergo apoptosis. Here, we present evidence that Erythropoietin receptor (Epor) signaling not only has a role in FVA cell survival, but is also required for the induction of terminal differentiation. Further, the transcription factors Signal Transducer and Activator of Transcription-5a and -5b (Stat5ab) are required. Our objective is to elucidate the pathway, downstream of Stat5, which induces differentiation. In FVA cells, we hypothesize that Stat5 activates the expression of target genes, which feedback on Sf-Stk and/or Epor signaling to induce terminal differentiation. To test this hypothesis, we propose a series of experiments. Our first aim is to define the Stat5-dependent pathway. We propose to identify direct Stat5 targets with microarrays; to identify Stat5-dependent changes in the signaling pathways downstream of Sf-Stk and Epor; to identify Stat5-dependent changes in cellular proteins and posttranslational modifications; to identify Stat5-dependent changes in protein interactions; and to map sites of post-translational modifications. Our second aim is to examine the role of specific Stat5 targets in FVA cell differentiation. We propose to study the role of known Stat5 targets, Cis and Socs3, in FVA cells derived from Cis-/- mice, and FVA cells derived from Socs3-/- fetal liver cell transplant recipients. We also propose to study the role of a potential Stat5 target, Insulin receptor substrate-2 (Irs2), in FVA cells derived from Irs2-/- mice. Irs2 activates some of the same signaling pathways as the distal Epor. So, we will determine whether Irs2 is functionally redundant with the distal Epor in normal erythroid cells.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of NIX in Erythroid Maturation
-
批准号:7077524
-
项目类别:
-
资助金额:$24.28万
-
财政年份:2006
-
负责人:PAUL A NEY
-
依托单位:
Role of NIX in Erythroid Maturation
-
批准号:7244084
-
项目类别:
-
资助金额:$20.0万
-
财政年份:2006
-
负责人:PAUL A NEY
-
依托单位:
ROLE OF FV2 IN ERYTHROPOIESIS
-
批准号:6475866
-
项目类别:
-
资助金额:$22.59万
-
财政年份:1999
-
负责人:PAUL A NEY
-
依托单位:
Mechanisms of erythroid differentiation
-
批准号:7066608
-
项目类别:
-
资助金额:$24.9万
-
财政年份:1999
-
负责人:PAUL A NEY
-
依托单位:
Mechanisms of erythroid differentiation
-
批准号:7234681
-
项目类别:
-
资助金额:$24.18万
-
财政年份:1999
-
负责人:PAUL A NEY
-
依托单位:
Mechanisms of erythroid differentiation
-
批准号:7616149
-
项目类别:
-
资助金额:$24.18万
-
财政年份:1999
-
负责人:PAUL A NEY
-
依托单位:
Mechanisms of erythroid differentiation
-
批准号:7384451
-
项目类别:
-
资助金额:$24.18万
-
财政年份:1999
-
负责人:PAUL A NEY
-
依托单位:
NF-E2 BINDING SITES AND GLOBIN GENE REGULATION
-
批准号:2909958
-
项目类别:
-
资助金额:$20.65万
-
财政年份:1999
-
负责人:PAUL A NEY
-
依托单位:
ROLE OF FV2 IN ERYTHROPOIESIS
-
批准号:6624703
-
项目类别:
-
资助金额:$23.27万
-
财政年份:1999
-
负责人:PAUL A NEY
-
依托单位:
NF-E2 BINDING SITES AND GLOBIN GENE REGULATION
-
批准号:6177551
-
项目类别:
-
资助金额:$20.17万
-
财政年份:1999
-
负责人:PAUL A NEY
-
依托单位:
NF-E2 BINDING SITES AND GLOBIN GENE REGULATION
-
批准号:6381078
-
项目类别:
-
资助金额:$20.77万
-
财政年份:1999
-
负责人:PAUL A NEY
-
依托单位:
NF-E2 BINDING SITES AND GLOBIN GENE REGULATION
-
批准号:6523698
-
项目类别:
-
资助金额:$21.4万
-
财政年份:1999
-
负责人:PAUL A NEY
-
依托单位:
ROLE OF FV2 IN ERYTHROPOIESIS
-
批准号:6329104
-
项目类别:
-
资助金额:$21.93万
-
财政年份:1999
-
负责人:PAUL A NEY
-
依托单位:
ROLE OF FV2 IN ERYTHROPOIESIS
-
批准号:6038545
-
项目类别:
-
资助金额:$21.62万
-
财政年份:1999
-
负责人:PAUL A NEY
-
依托单位:
ROLE OF FV2 IN ERYTHROPOIESIS
-
批准号:6684118
-
项目类别:
-
资助金额:$23.96万
-
财政年份:1999
-
负责人:PAUL A NEY
-
依托单位:
OXIDATION AND DEFORMATION IN SICKLE RBC DEHYDRATION
-
批准号:3050559
-
项目类别:
-
资助金额:$2.9万
-
财政年份:1987
-
负责人:PAUL A NEY
-
依托单位:
海外基金